Healthcare & Life Sciences

The Netherlands: Europe’s Most Attractive Life Sciences Hotspot, or the Next Big Troublemaker?

July 1, 2019
Healthcare & Life SciencesPublic & Government Affairs

The Netherlands certainly has a lot going for it when it comes to attracting the world’s leading biopharmaceutical companies: World-class research institutes, a well-respected healthcare system and not least of all the new home of the European Medicines Agency.

FTI Consulting Brussels and IvCB explore whether there is another side to the story. Read more here- A New Healthcare Hotspot?

Related Articles

Predictions for Cybersecurity in 2024: Communications and Reputational Perspectives

March 7, 2024—What will the cybersecurity space look like in 2024? And what do companies need to do to ensure they are prepared from a...
Cybersecurity in Latin America: Cyber Threats Evolve in a Landscape of Incipient Resilience

January 25, 2024—Organizations in Latin America should not wait for regulators to impose cybersecurity readiness requirements, as prepara...
A Year of Elections in Latin America: Navigating Political Cycles, Seizing Long-term Opportunity

January 23, 2024—Around 4.2 billion people will go to the polls in 2024, in what many are calling the biggest electoral year in history.[...
FTI Consulting News Bytes – 5 July 2024

July 5, 2024—FTI Consulting News Bytes While the eyes of the UK media have been firmly fixed on the General Election this week, there...
2024 UK General Election: The Results – ‘Need to Know’ Morning Update

July 5, 2024—The results – as it stands 08:30, Friday 5th July 2024 The topline With almost all the results declared, the Labour Pa...
ESG+ Newsletter – 4 July 2024

July 4, 2024—Happy 4th of July to all our US readers! In this week’s newsletter, we cover a range of developments globally, from ca...